Keywords: Pfizer, China opportunities, Shanghair Pharma, Prevenar, MoU

Pfizer views China opportunities, signing MoU with Shanghai Pharma

Article | 21 April 2011

Global drugs behemoth Pfizer (NYSE: PFE) has signed a memorandum of understanding (MOU) with Shanghai Pharmaceutical (SHSE: 601607) for the companies ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Pfizer

Shanghai Pharmaceutical Group

Go to company listing

Related Drugs

Prevenar

Go to drug listing